Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) has returned 10.92% so far this year and 43.65% over the past 12 months.
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
- 1D
- 4.46%
- 1M
- -6.68%
- YTD
- 10.92%
- 6M
- 23.74%
- 1Y
- 43.65%
- 3Y*
- 8.86%
- 5Y*
- -8.02%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Jun 13, 2019, IDNA's average daily return is +0.03%, while the average monthly return is +0.52%. At this rate, your investment would double in approximately 11.1 years.
Historically, 51% of months were positive and 49% were negative. The best month was Nov 2020 with a return of +17.9%, while the worst month was Jan 2022 at -17.1%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 9 months.
On a daily basis, IDNA closed higher 51% of trading days. The best single day was Jun 17, 2019 with a return of +7.7%, while the worst single day was Mar 12, 2020 at -10.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 8.86% | 9.19% | -6.68% | 10.92% | |||||||||
| 2025 | 0.75% | -1.32% | -8.93% | 2.59% | -3.76% | 2.12% | 3.61% | 4.27% | 6.58% | 7.37% | 8.66% | -4.38% | 17.26% |
| 2024 | -3.13% | 8.61% | -0.54% | -6.19% | 4.96% | -2.04% | 7.27% | 0.65% | -1.39% | -1.97% | 2.45% | -8.02% | -0.72% |
| 2023 | 7.03% | -10.62% | -3.36% | 0.73% | 1.71% | -1.76% | 2.68% | -6.18% | -9.55% | -10.96% | 13.85% | 12.37% | -7.63% |
| 2022 | -17.12% | -4.21% | -0.95% | -13.64% | -3.63% | 1.28% | 9.55% | -6.26% | -11.08% | 3.26% | 3.27% | -10.55% | -42.28% |
| 2021 | 9.60% | -6.63% | -2.77% | 4.90% | -2.34% | 11.22% | -3.69% | 7.50% | -5.87% | -2.01% | -4.53% | -7.12% | -3.98% |
Benchmark Metrics
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund has an annualized alpha of -5.18%, beta of 0.91, and R² of 0.38 versus S&P 500 Index. Calculated based on daily prices since June 14, 2019.
- This ETF participated in 120.66% of S&P 500 Index downside but only 83.84% of its upside — more exposed to losses than it benefited from rallies.
- R² of 0.38 means the benchmark explains less than half of this ETF's behavior — treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- -5.18%
- Beta
- 0.91
- R²
- 0.38
- Upside Capture
- 83.84%
- Downside Capture
- 120.66%
Expense Ratio
IDNA has an expense ratio of 0.47%, placing it in the medium range.
Return for Risk
Risk / Return Rank
IDNA ranks 82 for risk / return — in the top 82% of ETFs on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and compare them to a chosen benchmark (S&P 500 Index).
| IDNA | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.58 | 0.90 | +0.69 |
Sortino ratioReturn per unit of downside risk | 2.21 | 1.39 | +0.83 |
Omega ratioGain probability vs. loss probability | 1.26 | 1.21 | +0.05 |
Calmar ratioReturn relative to maximum drawdown | 3.20 | 1.40 | +1.80 |
Martin ratioReturn relative to average drawdown | 10.48 | 6.61 | +3.88 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore IDNA risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund provided a 1.06% dividend yield over the last twelve months, with an annual payout of $0.31 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend | $0.31 | $0.31 | $0.22 | $0.24 | $0.14 | $0.31 | $0.12 | $0.24 |
Dividend yield | 1.06% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
Monthly Dividends
The table displays the monthly dividend distributions for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.16 | $0.31 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.11 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.11 | $0.22 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.17 | $0.24 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.14 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.14 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.26 | $0.31 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund was 68.26%, occurring on Oct 27, 2023. The portfolio has not yet recovered.
The current iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund drawdown is 45.31%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -68.26% | Sep 3, 2021 | 541 | Oct 27, 2023 | — | — | — |
| -26.93% | Mar 5, 2020 | 8 | Mar 16, 2020 | 23 | Apr 17, 2020 | 31 |
| -22.23% | Feb 9, 2021 | 19 | Mar 8, 2021 | 107 | Aug 9, 2021 | 126 |
| -14.38% | Jul 19, 2019 | 58 | Oct 9, 2019 | 30 | Nov 20, 2019 | 88 |
| -13.58% | Jul 21, 2020 | 35 | Sep 8, 2020 | 23 | Oct 9, 2020 | 58 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...